BNP-7787 (BioNumerik/Baxter Oncology/Grelan).

BNP-7787 (BioNumerik/Baxter Oncology/Grelan).

IDrugs : the investigational drugs journal (2004-01-20)

R Todd Reilly

要旨

BioNumerik Pharmacology Inc, Baxter Oncology GmbH (formerly ASTA Medica AG) and Grelan Pharmaceutical Co Ltd are developing BNP-7787 for the potential reduction of toxicity associated with cisplatin and carboplatin treatment in cancer patients.

材料

製品番号

ブランド

製品内容

Y0000317

Mesna impurity D, European Pharmacopoeia (EP) Reference Standard